| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,198 | 17,589 | 16,895 | 14,643 | | Cost of Revenue | 9,197 | 10,085 | 10,170 | 6,688 | | | Gross Profit | 7,001 | 7,504 | 6,725 | 7,955 | | | Operating Expenses | | Research Development | 1,289 | 1,408 | 1,526 | 1,284 | | Selling General and Administrative | 6,872 | 5,711 | 4,722 | 6,931 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,160) | 385 | 477 | (260) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16 | 24 | 34 | 38 | | Earnings Before Interest And Taxes | (1,144) | 409 | 511 | (222) | | Interest Expense | 377 | 375 | 419 | 450 | | Income Before Tax | (1,521) | 34 | 92 | (672) | | Income Tax Expense | 35 |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,556) | 34 | 92 | (672) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,556) | 34 | 92 | (672) | | Preferred Stock And Other Adjustments | (51) | (96) | (534) | (44) | | | Net Income Applicable To Common Shares | ($1,607) | ($62) | ($442) | ($716) |
|
0.26% Nasdaq 
0.08 (2.69%) 
Income Statement
